New tuberculosis vaccines are expected to be introduced to the market, with the potential to save 7.3 million lives. Tuberculosis remains one of the world's leading infectious disease killers, with low- and middle-income countries bearing the majority of cases and deaths. The development of these vaccines represents a significant advancement in global health efforts to combat the disease. The vaccines could play a crucial role in reducing the burden of TB worldwide.
Don't miss out on breaking stories and in-depth articles.
